Harfst & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-803
| Closed | -$349K | – | 105 |
|
|
2025
Q1 | $349K | Sell |
803
-110
| -12% | -$47.8K | 0.08% | 98 |
|
|
2024
Q4 | $337K | Sell |
913
-3,981
| -81% | -$1.47M | 0.07% | 75 |
|
|
2024
Q3 | $2.54M | Buy |
4,894
+341
| +7% | +$177K | 0.57% | 34 |
|
|
2024
Q2 | $2.47M | Sell |
4,553
-139
| -3% | -$75.3K | 0.58% | 28 |
|
|
2024
Q1 | $2.43M | Sell |
4,692
-19
| -0.4% | -$9.85K | 0.58% | 35 |
|
|
2023
Q4 | $2.22M | Sell |
4,711
-108
| -2% | -$50.9K | 0.59% | 37 |
|
|
2023
Q3 | $2.1M | Buy |
4,819
+19
| +0.4% | +$8.27K | 0.59% | 38 |
|
|
2023
Q2 | $2.13M | Buy |
4,800
+891
| +23% | +$396K | 0.57% | 40 |
|
|
2023
Q1 | $1.8M | Sell |
3,909
-20
| -0.5% | -$9.2K | 0.52% | 39 |
|
|
2022
Q4 | $2.02M | Sell |
3,929
-3
| -0.1% | -$1.54K | 0.58% | 29 |
|
|
2022
Q3 | $1.79M | Buy |
3,932
+320
| +9% | +$145K | 0.54% | 33 |
|
|
2022
Q2 | $1.74M | Sell |
3,612
-311
| -8% | -$150K | 0.49% | 28 |
|
|
2022
Q1 | $1.93M | Buy |
3,923
+337
| +9% | +$166K | 0.45% | 34 |
|
|
2021
Q4 | $1.66M | Buy |
3,586
+156
| +5% | +$72.3K | 0.42% | 44 |
|
|
2021
Q3 | $1.28M | Sell |
3,430
-67
| -2% | -$25K | 0.35% | 52 |
|
|
2021
Q2 | $1.34M | Buy |
3,497
+742
| +27% | +$283K | 0.39% | 49 |
|
|
2021
Q1 | $988K | Buy |
+2,755
| New | +$988K | 0.3% | 67 |
|